• Pfizer Asks FDA To Approve Its COVID-19 Vaccine For Emergency Use

    7 days ago - By NPR

    The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective. (Image credit: Justin Tallis/AFP via Getty Images)
    Read more ...

     

  • Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade

    Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade

    7 days ago - By NPR

    Albert Bourla, head of the pharmaceutical giant, discusses plans for distributing its vaccine, which it says is 95% effective, and explains the timing of his $5.6 mllion sale of Pfizer stock.
    Read more ...

     

  • US stocks waver as stimulus friction and rising virus cases overshadow vaccine hopes

    US stocks waver as stimulus friction and rising virus cases overshadow vaccine hopes

    7 days ago - By Business Insider

    Summary List Placement
    US stocks fluctuated on Friday as soaring COVID-19 cases and disagreement on new stimulus offset positive developments for vaccine distribution.
    Pfizer and BioNTech both gained ahead of plans to apply for emergency-use authorization for their experimental coronavirus vaccine. The FDA's vetting process is set to take a few weeks, teeing the shot up for an early 2021 rollout.
    The US reported a record 182,832 new COVID-19 cases on Thursday, according to The COVID Tracking Project. Cities continued to implement stricter lockdown measures to slow the virus's...
    Read more ...

     

  • US stocks waver as stimulus friction and rising virus cases overshadow vaccine hopes

    US stocks waver as stimulus friction and rising virus cases overshadow vaccine hopes

    7 days ago - By Business Insider

    Reuters / Lucas Jackson
    US stocks fluctuated on Friday as soaring COVID-19 cases and disagreement on new stimulus offset positive developments for vaccine distribution. Pfizer and BioNTech both gained ahead of plans to apply for emergency-use authorization for their experimental coronavirus vaccine. The FDA's vetting process is set to take a few weeks, teeing the shot up for an early 2021 rollout. The US reported a record 182,832 new COVID-19 cases on Thursday, according to The COVID Tracking Project. Cities continued to implement stricter lockdown measures to slow the virus's spread...
    Read more ...

     

  • Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval

    7 days ago - By Business Insider

    Dogukan Keskinkilic/Anadolu Agency via Getty Images
    Pfizer and BioNTech gained on Friday after saying they would submit their COVID-19 vaccine candidate to the FDA today for Emergency Use Authorization. The submission will potentially enable use of the vaccine in high-risk populations in the US by the middle to end of December, the companies said. The companies will be ready to distribute the vaccine within hours after authorization and expect to produce up to 50 million doses of its vaccine in 2020, and 1.3 billion doses by the end of 2021. Visit Business Insider's homepage for more...
    Read more ...

     

  • We can't rely on just one company to distribute COVID vaccines

    7 days ago - By Fortune

    With cases of COVID-19 surging across the country, there has been incredible urgency for a safe and effective vaccine. But there are sobering messages from public health officials and vaccine company executives in recent days that the vaccine likely won't be available to a majority of the U.S. population until well into 2021.
    The approval of a vaccine, however, will only be the first step toward restoring the health and security of our nation. There is an important distinction between the creation of a vaccine designed to prevent the spread of COVID-19 and a successful process of...
    Read more ...

     

  • Pfizer, BioNTech To Seek Emergency Approval For Covid-19 Vaccine On Friday

    7 days ago - By Forbes

    Clinical trials show the vaccine to be 95% effective at preventing Covid-19.
    Read more ...

     

  • Inside the COVID-19 vaccine airlift: How cargo carriers plan to distribute the world's soon-to-be most valuable drugs to market

    7 days ago - By Business Insider

    Cargo planes will be crucial is getting a COVID-19 vaccine to the furthest reaches of the world in the shortest time.
    Oed/ullstein bild/Getty
    Air cargo carriers are gearing up to transport a vaccine for the novel coronavirus if one is approved, in the second COVID-19 airlift of 2020.
    Each vaccine comes with its own requirements for shipping, with Pfizer's being among the most challenging as it requires storage temperatures of -94 degrees Fahrenheit, presenting a problem for aircraft.
    Vaccines from Moderna and Johnson & Johnson can more easily be transported as they have less strict...
    Read more ...